{"id":838,"date":"2017-07-24T15:41:56","date_gmt":"2017-07-24T14:41:56","guid":{"rendered":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?p=838"},"modified":"2017-07-24T15:43:21","modified_gmt":"2017-07-24T14:43:21","slug":"alvogen-recalls-24-lots-hypertension-due-chemical-contamination","status":"publish","type":"post","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","title":{"rendered":"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination"},"content":{"rendered":"<p>A medical drug manufacturer has initiated a voluntary recall on 3rd July 2017 after concerns their Nifedipine tablets have become contaminated with other medication ingredients.<\/p>\n<p>The company, based in Iceland, makes the hypertension drug under the brand name Adalat, which is supplied to Bayer HeathCare. It&#8217;s used for channel blocking and as treatment for hypertension (high blood pressure).<\/p>\n<p>The recall was initiated after a potential cross-contamination between the Nifedipine and another drug in the same facility.<br \/>\n<!--more--><br \/>\nIt&#8217;s believed an inlet air duct may have transferred residual Sorafenib powder into the Nifedipine. Sorafenib is a drug used for chemotherapy treatment.<\/p>\n<p>The Sorafenib residue that may have been unintentionally transferred into Alvogen&#8217;s Adalat is used to treat cancer. Chemotherapy drugs are notorious for severe side effects, so the worry is that anyone using a contaminated batch of the medicine may in turn suffer the horrendous side-effects that come with chemotherapy medication.<\/p>\n<p>Sorafenib&#8217;s extensive list of side effects include:<\/p>\n<div class=\"well\">\n<ul>\n<li>Stomach pain or bloating<\/li>\n<li>Coughing up, vomiting, or excreting blood<\/li>\n<li>Blurred vision<\/li>\n<li>Respiratory problems<\/li>\n<li>Paralysis<\/li>\n<li>Nosebleeds<\/li>\n<li>Jaundice<\/li>\n<li>Nausea<\/li>\n<li>Increased menstrual flow or vaginal bleeding<\/li>\n<li>General pain and discomfort<\/li>\n<li>Convulsions<\/li>\n<li>Rashes<\/li>\n<\/ul>\n<\/div>\n<p>The list goes on but there is a worrying amount of side-effects involving blood loss. Another one of the common side effects is hypertension; not good news when the purpose of taking Adalat is to treat hypertension&#8230;<\/p>\n<h2>The recall<\/h2>\n<p>The drug-maker has recalled 24 lots of the medication with the expiry date of January 2019. Patients with hypertension who are relying on these drugs to relieve high blood pressure may need to seek urgent medical advice in the event their medication is contaminated; particularly where users are suffering side-effects associated with chemotherapy medication.<\/p>\n<p>Patients who suffer from injury because of defective products have every right to seek legal redress if manufacturers are found to be negligent. Patients with hypertension should be able to take Adalat to treat their condition without worrying there may be traces of chemotherapy drugs that could in fact increase their high blood pressure and cause serious health complications.<\/p>\n<p>If you have been adversely affected by a product, you could be eligible to claim compensation. Talk to our <a href=\"\/\" target=\"_blank\" style=\"font-weight: bold;\">expert lawyers who specialise in consumer protection laws<\/a> to see how we can help today.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A medical drug manufacturer has initiated a voluntary recall on 3rd July 2017 after concerns their Nifedipine tablets have become contaminated with other medication ingredients. The company, based in Iceland, makes the hypertension drug under the brand name Adalat, which is supplied to Bayer HeathCare. It&#8217;s used for channel blocking and as treatment for hypertension &hellip; <a href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[5],"tags":[8],"class_list":["post-838","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical","tag-recalls"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination\" \/>\n<meta property=\"og:description\" content=\"A medical drug manufacturer has initiated a voluntary recall on 3rd July 2017 after concerns their Nifedipine tablets have become contaminated with other medication ingredients. The company, based in Iceland, makes the hypertension drug under the brand name Adalat, which is supplied to Bayer HeathCare. It&#8217;s used for channel blocking and as treatment for hypertension &hellip; Continue reading Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\" \/>\n<meta property=\"og:site_name\" content=\"Group Action Lawyers\" \/>\n<meta property=\"article:published_time\" content=\"2017-07-24T14:41:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-07-24T14:43:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"614\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\"},\"author\":{\"name\":\"Admin\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"headline\":\"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination\",\"datePublished\":\"2017-07-24T14:41:56+00:00\",\"dateModified\":\"2017-07-24T14:43:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\"},\"wordCount\":386,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"keywords\":[\"recalls\"],\"articleSection\":[\"Medical\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\",\"name\":\"Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"datePublished\":\"2017-07-24T14:41:56+00:00\",\"dateModified\":\"2017-07-24T14:43:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/www.groupactionlawyers.co.uk\\\/blog\\\/wp-content\\\/uploads\\\/2016\\\/11\\\/drugs-recall-750x250.png?fit=750%2C250&ssl=1\",\"width\":750,\"height\":250,\"caption\":\"drugs\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/\",\"name\":\"Group Action Lawyers\",\"description\":\"Latest Legal News, Articles &amp; Opinions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/#\\\/schema\\\/person\\\/3c954adf13d2913933b2069fbd6df781\",\"name\":\"Admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g\",\"caption\":\"Admin\"},\"url\":\"https:\\\/\\\/www.groupactionlawyers.co.uk\\\/blog\\\/author\\\/admin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","og_locale":"en_GB","og_type":"article","og_title":"Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination","og_description":"A medical drug manufacturer has initiated a voluntary recall on 3rd July 2017 after concerns their Nifedipine tablets have become contaminated with other medication ingredients. The company, based in Iceland, makes the hypertension drug under the brand name Adalat, which is supplied to Bayer HeathCare. It&#8217;s used for channel blocking and as treatment for hypertension &hellip; Continue reading Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination","og_url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","og_site_name":"Group Action Lawyers","article_published_time":"2017-07-24T14:41:56+00:00","article_modified_time":"2017-07-24T14:43:21+00:00","og_image":[{"width":1200,"height":614,"url":"https:\/\/i2.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1","type":"image\/png"}],"author":"Admin","twitter_card":"summary_large_image","twitter_image":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall.png?fit=1200%2C614&ssl=1","twitter_misc":{"Written by":"Admin","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#article","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination"},"author":{"name":"Admin","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"headline":"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination","datePublished":"2017-07-24T14:41:56+00:00","dateModified":"2017-07-24T14:43:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination"},"wordCount":386,"commentCount":0,"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","keywords":["recalls"],"articleSection":["Medical"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination","name":"Alvogen Recalls 24 Lots Of Hypertension Drug Due To Chemical Contamination","isPartOf":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage"},"image":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","datePublished":"2017-07-24T14:41:56+00:00","dateModified":"2017-07-24T14:43:21+00:00","author":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781"},"breadcrumb":{"@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#primaryimage","url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","width":750,"height":250,"caption":"drugs"},{"@type":"BreadcrumbList","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/alvogen-recalls-24-lots-hypertension-due-chemical-contamination#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.groupactionlawyers.co.uk\/blog"},{"@type":"ListItem","position":2,"name":"Alvogen recalls 24 lots of hypertension drug off the market due to chemical contamination"}]},{"@type":"WebSite","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#website","url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/","name":"Group Action Lawyers","description":"Latest Legal News, Articles &amp; Opinions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.groupactionlawyers.co.uk\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.groupactionlawyers.co.uk\/blog\/#\/schema\/person\/3c954adf13d2913933b2069fbd6df781","name":"Admin","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80c638f202b7125d0217e22b6b80daa614813aec57ba35fb6741bb7737941f2c?s=96&d=mm&r=g","caption":"Admin"},"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/author\/admin"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1","jetpack-related-posts":[{"id":1750,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/are-you-suffering-with-valsartan-side-effects","url_meta":{"origin":838,"position":0},"title":"Are you suffering with valsartan side effects?","author":"Author","date":"25th March 2019","format":false,"excerpt":"If you\u2019re suffering with valsartan side effects, you may want to read this article and take heed of some important information about the drug. Last year, a Class 1 Medicines Recall was initiated by Medicines and Healthcare products Regulatory Agency (MHRA). The recall stems from potential contamination that comes from\u2026","rel":"","context":"In &quot;Latest&quot;","block_context":{"text":"Latest","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/latest"},"img":{"alt_text":"drugs alert","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/antibiotics-alert-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1537,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/lynparza-cancer-drug-recall-confirmed-by-uk-regulators","url_meta":{"origin":838,"position":1},"title":"Cancer drug recall confirmed by UK regulators","author":"Author","date":"13th April 2018","format":false,"excerpt":"A cancer drug recall has been initiated due to reports of excessive levels of an active ingredient used in the drug. Pharmaceutical company AstraZeneca UK has initiated the recall, primarily for batch NG327, because the \"level of olaparib polymorphic form L exceeds the registered specification limit\". As well as the\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drug recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/cancer-drug-recall.png?fit=1200%2C414&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":637,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/viridal-duo-powder-solvent-injections-recall","url_meta":{"origin":838,"position":2},"title":"The Government has issued a medical drug alert alongside a voluntary recall of Viridal Duo Powder amidst concerns over defective cap seals compromising the sterility of the contents.","author":"Admin","date":"2nd May 2017","format":false,"excerpt":"UCB Pharma Limited is voluntarily recalling their Viridial Duo Powder and Solvent for Injections after concerns that the cap seals are not strong enough. The cap seals are vulnerable to breaking and thus compromising the sterility of the contents. Viridal Duo Powder and Solvents contain the active ingredient 'Alprostadil' and\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/05\/viridial-duo-recall-min.jpg?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/05\/viridial-duo-recall-min.jpg?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/05\/viridial-duo-recall-min.jpg?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2017\/05\/viridial-duo-recall-min.jpg?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":249,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/beta-blockers-calcium-antagonists-can-lead-to-hospitalised-mood-disorders","url_meta":{"origin":838,"position":3},"title":"&#8220;Drugs that can give you mood swings&#8221; &#8211; Reports suggest that beta-blockers and calcium antagonists are medications that can lead to hospitalised mood disorders","author":"Admin","date":"25th November 2016","format":false,"excerpt":"Recent reports indicate that individuals taking medication known as beta-blockers and calcium antagonists for a period of more than 90 days may be susceptible to mood disorders that require hospital treatment. These medications - commonly used to control blood pressure - are said to be a possible cause for major\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":406,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/chewy-calcium-vitamin-d-tablets-being-recalled-for-impurities","url_meta":{"origin":838,"position":4},"title":"Chewy calcium and vitamin-D tablets are being recalled for impurities","author":"Admin","date":"28th December 2016","format":false,"excerpt":"Teva U.K. Limited - a global pharmaceutical company - has recalled a batch of class 2 medicines due to a possible metal contamination. The pharmaceutical company has recently made a precautionary batch recall for a 'small number' of Evacal D3 chewable tablets. The tablets are a calcium-vitamin D supplement used\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"drugs","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/2016\/11\/drugs-recall-750x250.png?fit=750%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":849,"url":"https:\/\/www.groupactionlawyers.co.uk\/blog\/diclo-sr-75-pain-relief-tablets-class-2-recall","url_meta":{"origin":838,"position":5},"title":"Class 2 recall for Diclo-SR 75 pain-relief tablets","author":"Admin","date":"28th July 2017","format":false,"excerpt":"A Watford-based pharmaceutical company has issued a voluntary recall for batches of Diclo-SR 75 pain relief tablets - AKA diclofenac sodium. The tablets are commonly used for pain relief and swelling for arthritis, musculoskeletal disorders, gout and pain caused by injury or minor surgery. The tablets are classified in a\u2026","rel":"","context":"In &quot;Medical&quot;","block_context":{"text":"Medical","link":"https:\/\/www.groupactionlawyers.co.uk\/blog\/category\/medical"},"img":{"alt_text":"pain relief tablets recall","src":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.groupactionlawyers.co.uk\/blog\/wp-content\/uploads\/pain-relief-tablets-recall-min.png?fit=725%2C250&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/838","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/comments?post=838"}],"version-history":[{"count":5,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/838\/revisions"}],"predecessor-version":[{"id":844,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/posts\/838\/revisions\/844"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media\/216"}],"wp:attachment":[{"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/media?parent=838"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/categories?post=838"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.groupactionlawyers.co.uk\/blog\/wp-json\/wp\/v2\/tags?post=838"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}